Korean College of Rheumatology Biologics and Targeted Therapy Registry
NCT01965132 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2024-04-26
Summary
We established a nationwide biologics and targeted synthetic DMARDs registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients receiving biologics or targeted synthetic DMARDs. As this registry is to observe the "real world" use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is planned.
Conditions
Interventions
- DRUG
-
Biologic or targeted synthetic DMARD
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Eun Yeong Lee, MD · Seoul National University Hospital
-
Tae-Hwan Kim, MD · Hanyang University
-
Shin-Seok Lee, MD · Chonnam National University Hospital
-
Jaejoon Lee, MD · SAMSUNG MEDICL CENTER
-
Changhoon Lee, MD · Wonkwang University Hospital
-
Chang-Keun Lee, MD · Asan Medical Center
-
Hyoun-Ah Kim, MD · Ajou University School of Medicine
-
Sang-Il Lee, MD · Gyeongsang National University Hospital
-
Jung-Yoon Choe, MD · Daegu Catholic University Medical Center
-
Jae Hyun Jung, MD · Korea University Ansan Hospital
-
Mi Ryoung Seo, MD · Gachon University Gil Medical Center
-
Jinseok Kim, MD · Jeju National University Hospital
-
Mihye Kwon, MD · KONYANG UNIV. HOSPITAL
-
Joo-Hyun Lee, MD · Inje University Ilsan Paik Hospital
-
Seong Wook Kang, MD · Chungnam National University Hospital
-
Kwi Young Kang, MD · THE CATHOLIC UNIV. OF KOREA INCHEON ST. MARY'S HOSPITAL
-
Sung Won Lee, MD · Dong-A University Hospital
-
Young-Beom Park, MD · Severance Hospital
-
Hyun-Sook Kim, MD · Soonchunhyang University Hospital
-
Dae Hyun Yu, MD · Hanyang University
-
Sang-Heon Lee, MD · Konkuk University Medical Center
-
Young Mo Kang, MD · Kyungpook National University Hospital
-
Ki Won Moon, MD · KangWon National University Hospital
-
Seung-Jae Hong, MD · Kyunghee University Medical Center
-
Sang-Hyun Kim, MD · Keimyung University Dongsan Medical Center
-
Gwan Gyu Song, MD · Korea University Guro Hospital
-
Jiwon Hwang, MD · Samsung Changwon Hospital
-
Sung Hae Chang, MD · Soonchunhyang University Hospital
-
JINHYUN KIM, MD · Chungnam National University Hospital
-
Joo-Hyun Lee, MD · INJE UNIVERSITY ILSAN PAIK HOSPTIAL
-
Wan Hee Ryu, MD · Chonbuk National University Hospital
-
In-Ah Choi, MD · Chungbuk National University Hospital
-
Hyun Ah Kim, MD · HALLYM UNIVERSITY HOSPITAL
-
Kichul Shin, MD · SMG-SNU Boramae Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-01
- Primary Completion
- 2029-12-31
- Completion
- 2030-06-30
- FDA Drug
- Yes
Countries
- South Korea
Study Locations
More Related Trials
-
Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis
NCT03011281 ·Status: UNKNOWN
-
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
NCT01709578 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis
NCT05082805 ·Status: UNKNOWN
-
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
NCT06625242 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
NCT04973787 ·Status: UNKNOWN
-
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
NCT04584541 ·Status: TERMINATED ·Phase: NA
-
A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)
NCT00732875 ·Status: COMPLETED ·Phase: PHASE3
-
A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)
NCT01511003 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
NCT01211834 ·Status: COMPLETED ·Phase: PHASE3
-
Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab
NCT02627924 ·Status: COMPLETED
-
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
NCT02451748 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis
NCT01999192 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
NCT04541810 ·Status: COMPLETED
-
A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis
NCT06686082 ·Status: ENROLLING_BY_INVITATION
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
NCT04115423 ·Status: UNKNOWN
-
Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 Therapy
NCT04281602 ·Status: UNKNOWN
-
A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
NCT00202852 ·Status: COMPLETED ·Phase: PHASE3
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
NCT06902519 ·Status: RECRUITING ·Phase: PHASE1
-
Italian Registry of Arthritis on Biologic Therapy
NCT01543594 ·Status: RECRUITING
-
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
NCT01481493 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases
NCT05026892 ·Status: UNKNOWN
-
An Open-label Study of GC012F in Rheumatoid Arthritis.
NCT07315503 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1